United States
Germany
Japan
United Kingdom
China
Products
Carrier-free (BSA/glycerol-free) HES1 mouse monoclonal antibody, clone OTI2H4 (formerly 2H4)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI4D1 (formerly 4D1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI2D5E12
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI2G1 (formerly 2G1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI4C5 (formerly 4C5)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI1B1 (formerly 1B1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI1F1 (formerly 1F1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) GLI1 mouse monoclonal antibody, clone OTI1B5 (formerly 1B5)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Target Symbol
Reactivities
Applications
Antibody Hosts
Knockout (KO) Validation
Conjugates
Isotypes
Clonalities
Brands
Pathways
- Pathways in cancer (50)
- Basal cell carcinoma (30)
- Hedgehog signaling pathway (30)
- Chronic myeloid leukemia (20)
- ECM-receptor interaction (19)
- Hematopoietic cell lineage (19)
- Jak-STAT signaling pathway (16)
- Notch signaling pathway (16)
- Acute myeloid leukemia (15)
- ErbB signaling pathway (11)
- Cell cycle (9)
- Maturity onset diabetes of the young (8)
- Huntington's disease (5)
- Bladder cancer (4)
- Colorectal cancer (4)
- Endometrial cancer (4)
- Focal adhesion (4)
- Glioma (4)
- Melanoma (4)
- Non-small cell lung cancer (4)
- Pancreatic cancer (4)
- Prostate cancer (4)
- Small cell lung cancer (4)
- Thyroid cancer (4)
- Viral myocarditis (4)
- Wnt signaling pathway (4)
- p53 signaling pathway (4)
- Dorso-ventral axis formation (3)
- Prion diseases (3)
- Cytokine-cytokine receptor interaction (1)
